Aspen Aerogels (NYSE:ASPN) Releases Q1 2025 Earnings Guidance

Aspen Aerogels (NYSE:ASPN) issued an update on its first quarter 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of -0.180-0.000 for the period, compared to the consensus EPS estimate of 0.080. The company issued revenue guidance of $75.0 million-$95.0 million, compared to the consensus revenue estimate of $104.2 million.

Aspen Aerogels Price Performance

Shares of NYSE ASPN traded down $0.36 during trading hours on Wednesday, hitting $11.78. 4,444,883 shares of the stock were exchanged, compared to its average volume of 1,624,350. Aspen Aerogels has a 1-year low of $10.67 and a 1-year high of $33.15. The company has a market cap of $966.55 million, a PE ratio of 1,179.18 and a beta of 2.14. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The company’s fifty day simple moving average is $12.41 and its two-hundred day simple moving average is $18.68.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. On average, sell-side analysts predict that Aspen Aerogels will post 0.12 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a report on Saturday. Piper Sandler decreased their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Barclays dropped their price target on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday, November 12th. Canaccord Genuity Group reduced their price objective on Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating on the stock in a research report on Thursday, January 16th. Finally, HC Wainwright reiterated a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a research report on Wednesday, October 16th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Aspen Aerogels currently has an average rating of “Moderate Buy” and a consensus price target of $29.11.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.